Sherman Strong

We are raising money to support innovative research and care for kids with sickle cell disease at Children’s Hospital of Philadelphia (CHOP). 100,000 Americans live with sickle cell disease, and CHOP cares for more than 1,000 patients with sickle cell disease annually. Two gene therapies are now available — an incredible breakthrough for patients! But CHOP’s work is far from done. CHOP researchers are working on ways to make gene therapy treatment even better and without the need for chemotherapy. This approach could expand access and reduce the cost of gene therapies. Help us find new treatment options for families who need it most.

Why I Walk:

Children with sickle cell disease can experience excruciating pain, repeated visits to the Emergency Department and have a high risk of stroke. While the FDA recently approved two transformative gene therapies for sickle cell disease, there is still much work to be done. CHOP is a pioneer in treatment using gene and cell therapy and is therefore poised to create the next generation of gene therapies that are more effective and more widely available. CHOP’s Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED) provides comprehensive evaluation to each patient and family, and guides children from management of a chronic disease to exploring the potential for a curative therapy. 

How Can You Help?

By donating to support sickle cell disease research at Children's Hospital of Philadelphia, you are offering sick children and their families hope for a future free of disease.

Thank you for your support!